13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001892770
Total reported value
$189.2M
$189.2M
99 檔
74.4%
The Q2 2024 SEC filing reveals that Knott David M Jr held a total portfolio value of $189.2M, covering 99 public equity positions.
During Q2 2024, Knott David M Jr's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
In terms of portfolio concentration, the top 5 core holdings (including CLMTUSD, APO, GOOG) accounted for 74.4% of total reported equity market value during Q2 2024.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CLMTUSD | Calumet Specialty Products | Stock-Other | 27.70% | — | — | |
| 2 | APO | Apollo Global Management Inc | Stock-Financials | 10.60% | -0.85% | — | |
| 3 | GOOG | Alphabet Inc-cl C | Stock-Comm Services | 8.21% | +1.46% | — | |
| 4 | CLOZ | Eldridge Bbb-b Clo ETF | ETF-Other | 5.84% | -0.06% | -24.54% | |
| 5 | DCGO | Docgo Inc | Stock-Other | 3.79% | -0.27% | +59.52% | |
| 6 | LGND | Ligand Pharmaceuticals | Stock-Healthcare | 2.86% | — | -26.09% | |
| 7 | PFE | Pfizer Inc | Stock-Healthcare | 2.78% | -0.13% | +0.48% | |
| 8 | ICLO | Invesco Aaa Clo F/r Note ETF | ETF-Other | 2.44% | — | -22.56% | |
| 9 | ARDX | Ardelyx Inc | Stock-Other | 2.29% | -0.03% | -6.32% | |
| 10 | MFCSF | Medical Facilities CORP | Stock-Other | 1.97% | — | — | |
| 11 | ✓ | Avadel Pharmaceuticals PLC ADR | Stock-Other | 1.87% | — | — | |
| 12 | JPM | Jpmorgan Chase & Co | Stock-Financials | 1.69% | -0.28% | — | |
| 13 | OABI | Omniab Inc | Stock-Other | 1.67% | — | +1.36% | |
| 14 | VKTX | Viking Therapeutics Inc | Stock-Healthcare | 1.61% | — | -25.04% | |
| 15 | CPRX | Catalyst Pharmaceuticals Inc | Stock-Healthcare | 1.31% | -1.77% | EXIT | |
| 16 | VRNA | Verona Pharma PLC - Adr | Stock-Other | 1.17% | — | +76.52% | |
| 17 | JAAA | Janus Henderson Aaa Clo ETF | ETF-Other | 1.08% | -0.30% | -57.31% | |
| 18 | DMRC | Digimarc Corporation | Stock-Other | 1.03% | — | — | |
| 19 | ✓ | Inozyme Pharma Inc | Stock-Other | 1.00% | — | — | |
| 20 | GSK | Gsk Plc-spon Adr | Stock-Healthcare | 1.00% | — | — | |
| 21 | IMVT | Immunovant Inc | Stock-Other | 0.96% | — | +7.27% | |
| 22 | IRWD | Ironwood Pharmaceuticals Inc | Stock-Other | 0.96% | — | +34.06% | |
| 23 | CSX | Csx CORP | Stock-Industrials | 0.93% | — | — | |
| 24 | ESGRP | Enstar Group Limited - Deposita | Stock-Other | 0.91% | — | — | |
| 25 | TVTX | Travere Therapeutics Inc | Stock-Other | 0.87% | +1.93% | +15.15% | |
| 26 | SNDX | Syndax Pharmaceuticals Inc | Stock-Other | 0.85% | -0.82% | +58.57% | |
| 27 | LKNCY | Luckin Coffee Inc - Adr | Stock-Other | 0.84% | — | — | |
| 28 | BCRX | Biocryst Pharmaceuticals Inc | Stock-Other | 0.77% | — | — | |
| 29 | XERS | Xeris Biopharma Holdings Inc | Stock-Other | 0.74% | +0.78% | +36.67% | |
| 30 | PTGX | Protagonist Therapeutics Inc | Stock-Other | 0.72% | +0.13% | — | |
| 31 | AB | Alliancebernstein Holding LP | Stock-Other | 0.66% | -0.18% | — | |
| 32 | ✓ | Janus Henderson AAA CLO ETF | ETF-Other | 0.64% | — | — | |
| 33 | VRTX | Vertex Pharmaceuticals Inc | Stock-Healthcare | 0.56% | — | — | |
| 34 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 0.52% | +0.11% | -12.50% | |
| 35 | RHP | Ryman Hospitality Properties | Stock-Real Estate | 0.48% | +0.03% | — | |
| 36 | EOLS | Evolus Inc | Stock-Other | 0.47% | -0.24% | EXIT | |
| 37 | MDLZ | Mondelez International Inc-a | Stock-Consumer Staples | 0.37% | -0.01% | — | |
| 38 | ABBV | Abbvie Inc | Stock-Healthcare | 0.34% | — | — | |
| 39 | MREO | Mereo Biopharma Group Pl-adr | Stock-Other | 0.34% | -0.06% | EXIT | |
| 40 | KMB | Kimberly-clark CORP | Stock-Consumer Staples | 0.33% | — | — | |
| 41 | EDIT | Editas Medicine Inc | Stock-Other | 0.33% | — | +26.43% | |
| 42 | XENE | Xenon Pharmaceuticals Inc | Stock-Other | 0.32% | — | -12.57% | |
| 43 | 6D8 | Dupont De Nemours Inc | Stock-Other | 0.32% | -0.10% | EXIT | |
| 44 | MSFT | Microsoft CORP | Stock-Tech | 0.29% | -0.03% | — | |
| 45 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 0.27% | — | +18.42% | |
| 46 | CTVA | Corteva Inc | Stock-Materials | 0.25% | -0.01% | — | |
| 47 | CNQ | Canadian Natural Resources | Stock-Energy | 0.24% | -0.14% | +100.00% | |
| 48 | DOW | Dow Inc | Stock-Materials | 0.24% | -0.01% | — | |
| 49 | BBIO | Bridgebio Pharma Inc | Stock-Healthcare | 0.21% | -0.32% | +31.25% | |
| 50 | AAPL | Apple Inc | Stock-Tech | 0.21% | — | — |
According to official SEC Form 13F filings, Knott David M Jr reported a total U.S. public equity portfolio value of $189.2M across 99 disclosed positions in Q2 2024.
During Q2 2024, Knott David M Jr's top holdings by market value included CLMTUSD (27.7%)、APO (10.6%)、GOOG (8.2%). The largest single position, CLMTUSD, represented 27.7% of total portfolio value.
In Q2 2024, Knott David M Jr made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.